Your browser doesn't support javascript.
loading
Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis.
Robertson, Jamie; Porter, Duncan; Sattar, Naveed; Packard, Chris J; Caslake, Muriel; McInnes, Iain; McCarey, David.
Afiliação
  • Robertson J; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.
  • Porter D; Department of Rheumatology, Gartnavel General Hospital, Glasgow, UK.
  • Sattar N; Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.
  • Packard CJ; Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.
  • Caslake M; Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.
  • McInnes I; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.
  • McCarey D; Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK.
Ann Rheum Dis ; 76(11): 1949-1952, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28916714

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Interleucina-6 / Antirreumáticos / Anticorpos Monoclonais Humanizados / LDL-Colesterol Tipo de estudo: Evaluation_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Interleucina-6 / Antirreumáticos / Anticorpos Monoclonais Humanizados / LDL-Colesterol Tipo de estudo: Evaluation_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article